Signal26 Biotherapeutics is a biotechnology startup dedicated to advancing a novel antibody for treating psoriasis. In collaboration with interdisciplinary experts, we lead research into interleukin 26 (IL-26) and its role in the signalling pathways involved in autoimmune disorders.

Some insights
Location
Additional address info
  • StartLab
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2024
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in